2012
DOI: 10.1002/lsm.21130
|View full text |Cite
|
Sign up to set email alerts
|

Can fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model?

Abstract: This study demonstrates that laser pretreatment significantly increases absorption of topical lidocaine so that it is detectable in the blood and that manipulating laser settings can affect drug absorption. Future work will look at translating this effect into clinical benefit.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
47
0
4

Year Published

2012
2012
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(52 citation statements)
references
References 31 publications
1
47
0
4
Order By: Relevance
“…FLMA can promote penetration of the particles and drugs into dermis to the depth defined by parameters of laser system [7][8][9][10][11][21][22][23]. Thus, in Ref [21] authors used the laser fluence 125 J/cm 2 to induce areas with ablative depth up to 500 μm within the area of ablation of 1cm 2 .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…FLMA can promote penetration of the particles and drugs into dermis to the depth defined by parameters of laser system [7][8][9][10][11][21][22][23]. Thus, in Ref [21] authors used the laser fluence 125 J/cm 2 to induce areas with ablative depth up to 500 μm within the area of ablation of 1cm 2 .…”
Section: Resultsmentioning
confidence: 99%
“…Thus, in Ref [21] authors used the laser fluence 125 J/cm 2 to induce areas with ablative depth up to 500 μm within the area of ablation of 1cm 2 . The developed FLMA-protocol has allowed us to provide a comparable ablative depth (~400 μm) with the significantly smaller (~0.1 cm 2 ) area in rat skin in vivo at the approximately similar laser fluence ~100 J/cm 2 that promotes much better skin healing.…”
Section: Resultsmentioning
confidence: 99%
“…In recent years it has been demonstrated in several in vitro and in vivo experimental studies that pretreatment of the skin with ablative fractional lasers (AFXL) enhances the uptake of topically applied drugs into the skin, facilitates intracutaneous biodistribution and also enhances transcutaneous delivery [6][7][8][9][10][11][12][13][14][15][16][17]. Ablative fractional procedures are available with carbon dioxide (CO 2 ; 10,600 nm), erbium: yttrium aluminum garnet (Er:YAG; 2940 nm) and yttrium scandium gallium garnet (YSGG; 2790 nm) lasers [18][19][20].…”
Section: Introductionmentioning
confidence: 99%
“…The lasers can precisely control the ablation degree by adjustment of the energy and etched depth (Haedersdal et al, 2010;Yu et al, 2011;Oni et al, 2012;. The skin is exposed by the laser in a non-contact manner without the A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 5 contamination risk (Chen et al, 2012).…”
Section: Introductionmentioning
confidence: 99%